Ranbaxy Q1 net dips 90% to Rs 126 cr
New Delhi: Drug major Ranbaxy Laboratories on Wednesday posted a 89.91 percent decline in its consolidated net profit at Rs 125.75 crore for the first quarter ended March 31, 2013.
The company had posted a net profit of Rs 1,246.76 crore in the same period of previous year.
Net sales of the company declined to Rs 2,439.82 crore for the January-March quarter, compared to Rs 3,708.97 crore in the same period of 2012, Ranbaxy Laboratories Ltd said in a filing to the BSE.
Shares of Ranbaxy were trading at Rs 445 on the BSE in late afternoon trade, down 2.52 percent from its previous close.